Transient inhibition of ROR-?t therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells. (2016)

First Author: Withers DR

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/nm.4046

PubMed Identifier: 26878233

Publication URI: http://europepmc.org/abstract/MED/26878233

Type: Journal Article/Review

Volume: 22

Parent Publication: Nature medicine

Issue: 3

ISSN: 1078-8956